Michael Egholm, President and CEO of Standard BioTools Inc. ($LAB), made three open market sales of company stock over the past year, totaling $15,137. His most recent sale occurred on May 23, 2025. These transactions rank 11,155th out of 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 transactions per insider. Egholm reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 66127 | $1.15 | 5,551,710.0000 | 402,195,000 | 1.18% | 0.02% |
| Nov. 20, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 63529 | $1.28 | 5,617,837.0000 | 402,195,000 | 1.12% | 0.02% |
| Aug. 20, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 54919 | $1.27 | 5,681,366.0000 | 400,273,000 | 0.96% | 0.01% |
| Aug. 1, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | A | Common Stock | 3000000 | $0.00 | 5,736,285.0000 | 400,273,000 | 109.64% | 0.75% |
| May 28, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 9906 | $1.09 | 2,731,285.0000 | 397,667,000 | 0.36% | 0.00% |
| May 23, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | S | Common Stock | 5473 | $0.94 | 2,741,191.0000 | 397,667,000 | 0.20% | 0.00% |
| May 22, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | S | Common Stock | 5116 | $1.00 | 2,746,664.0000 | 397,667,000 | 0.19% | 0.00% |
| May 20, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 18343 | $1.05 | 2,756,499.0000 | 397,667,000 | 0.66% | 0.00% |
| May 21, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | S | Common Stock | 4719 | $1.03 | 2,751,780.0000 | 397,667,000 | 0.17% | 0.00% |
| April 4, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 57676 | $1.07 | 2,774,842.0000 | 397,667,000 | 2.04% | 0.01% |
| April 4, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | M | Restricted Stock Units | 196512 | $0.00 | 196,513.0000 | 397,667,000 | 50.00% | 0.05% |
| April 4, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | M | Common Stock | 196512 | $0.00 | 2,832,518.0000 | 397,667,000 | 7.45% | 0.05% |
| March 21, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | A | Common Stock | 1188333 | $0.00 | 2,636,006.0000 | 396,110,000 | 82.09% | 0.30% |
| March 21, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | A | Stock Option (Right to buy) | 1782500 | $0.00 | 1,782,500.0000 | 396,110,000 | 9999.99% | 0.45% |
| Feb. 20, 2025 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 31031 | $1.39 | 1,447,673.0000 | 396,110,000 | 2.10% | 0.01% |
| Nov. 20, 2024 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 28795 | $1.51 | 1,473,704.0000 | 390,841,000 | 1.92% | 0.01% |
| Aug. 20, 2024 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 29093 | $1.91 | 1,502,499.0000 | 389,703,000 | 1.90% | 0.01% |
| May 20, 2024 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | A | Common Stock | 1000000 | $0.00 | 1,531,592.0000 | 387,652,000 | 188.11% | 0.26% |
| May 20, 2024 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | A | Stock Option (Right to Buy) | 2250000 | $0.00 | 2,250,000.0000 | 387,652,000 | 9999.99% | 0.58% |
| April 8, 2024 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | F | Common Stock | 102564 | $2.71 | 531,592.0000 | 387,652,000 | 16.17% | 0.03% |
| April 5, 2024 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | A | Common Stock | 212126 | $0.00 | 634,156.0000 | 387,652,000 | 50.26% | 0.05% |
| April 4, 2024 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | M | Restricted Stock Units | 196512 | $0.00 | 393,025.0000 | 387,652,000 | 33.33% | 0.05% |
| April 4, 2024 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | M | Common Stock | 196512 | $0.00 | 422,030.0000 | 387,652,000 | 87.14% | 0.05% |
| Jan. 5, 2024 | STANDARD BIOTOOLS INC. | $LAB | Egholm Michael | President & CEO | A | Common Stock | 9006 | $0.00 | 225,518.0000 | 83,364,000 | 4.16% | 0.01% |